Christopher Carroll

Christopher Carroll's work experience includes being an Associate Director of Medicinal Chemistry at Kymera Therapeutics since 2023. Prior to that, they worked at the UT MD Anderson Cancer Center from 2012 to 2023, starting as an Institute Research Investigator before progressing to roles such as Principal Institute Research Scientist and Institute Senior Research Scientist. From 2010 to 2012, they were a Postdoctoral Researcher at UT Southwestern Medical Center at Dallas. Christopher also gained experience as a Graduate Research Associate at UC Irvine from 2005 to 2010, where they worked on total synthesis projects. Christopher had a summer internship at Neurocrine Biosciences in 2005 and was an Undergraduate Research Associate at SDSU from 2002 to 2005.

Christopher Carroll earned a Ph.D. in Organic Chemistry from UC Irvine from 2005 to 2010. Prior to that, they obtained a B.S. in Chemistry from San Diego State University from 2002 to 2005.